Overzicht Proefschriften

Tips in using the search/filter fields

Tips in using the search/filter fields
Select on a part of the content: ede Select exactly on a certain content: =ede
Select all fields that are NOT empty: >'' (two single quotes) Select all fields that are empty: =[spatie]
Select everything after a certain date: >31-12-2010 Select everything before a certain date: <31-12-2010
Select on a period containing the given date: >31-12-2010<1-2-2011 Type nu in a 'date' field to select everything between yesterday and tomorrow
By clicking a column title the table will be sorted on this column. If you then click the title of another column, the sort will be on this second column, preserving the first sort.
So if you want to sort on City and witghin that on Name, first click teh Name column and after that the City column. Click Reset to reset the filters and sorting.
Filters an sorting are saved and will be restored when you come back to this screen. Click Reset to reset the filters and sorting.
Go to page:
  • of 6

Displaying 1-50 of 278 results.
TitelPromovendusPromotor 1Promotor 2Copromotor 1Copromotor 2UniversiteitPromotiejaarTrefwoorden
Translating pharmacogenetics to primary care Swen J.J., PhDGuchelaar H.J., prof. dr.Assendelft W.J.J., prof. dr.Wessels J.A.M., dr.Universiteit Leiden (UL)2011Pharmacogenetics; Primary care;
Individualized dosing of calcineurin inhibitors in renal transplantationPress R.R., PhDGuchelaar H.J., prof. dr.Fijter J.W. de, prof. dr.Ploeger B.A., dr.Universiteit Leiden (UL)2011Kidney; Transplantation; Calcineurin inhibitors;
Treatment response in childhood asthmaVijverberg S.J.H., PhDRaaijmakers J.A.M., prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2014Treatment outcomes; Children; Asthma;
Towards better treatment outcomes in childhood asthmaKoster E.S., PhDRaaijmakers J.A.M., prof. dr.Maitland-van der Zee A.H., prof. dr.Universiteit Utrecht (UU)2011Asthma; Children; Treatment Outcomes; Epidemiology;
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factorsBatenburg W.W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Cardiac aldosterone: origin and effectsChai W., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2005Cardiovascular disease; Pharmacology;
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibitionEsch J.H.M. van, dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2008Cardiovascular disease; Pharmacology; Renin-angiotensin system;
(Pro)renin revisited: new insights from studies in mast cellsKrop M., dr.Danser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2009Cardiovascular disease; Pharmacology; Prorenin;
Natriuretic peptides, diagnostics and prognostic biomarkersRutte J.H.W., dr.Danser A.H.J., prof. dr.Meiracker A.H. van den, dr.Erasmus Universiteit Rotterdam (EUR)2010Antihypertensive drugs; Pharmacology; Kidney; Natriuretic peptides; Renine-angiotensine system;
Neurovascular pharmacology of prospective antimigraine drugsChan K.Y., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Migraine; Neurovascular pharmacology;
Aortic pathology and the role of the renin-angiotensin systemMolzer E., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The more complex renin-angiotensin system: new insights into an old systemGembardt F., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Pharmacology; Renin-angiotensin system;
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approachKappers M.H.W., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2011Cancer; Pharmacology; Antihypertensive drugs;
Red wine polyphenols and vascular functionBotden I.P.G., PhDDanser A.H.J., prof. dr.Sijbrands E.J.G., prof. dr.Langendonk J.G., dr.Erasmus Universiteit Rotterdam (EUR)2012Antihypertensive drugs; Cardiovascular disease; Pharmacology;
Vascular aging from DNA damage to protectionĎurik M., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2012Cardiovascular disease; Pharmacology;
The role of aldosterone and aldosterone blockade in hypertensionJansen P.M., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2013Cardiovascular disease; Antihypertensive drugs; Pharmacology;
Neurovascular pharmacology of migraine: epigenetics and sex hormonesLabruijere S., PhDDanser A.H.J., prof. dr.Maassen van den Brink A., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Migraine; Epigenetics; Neurovascular pharmacology;
Novel directions in therapy against age-related vascular diseaseWu H., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2014Pharmacology; Cardiovascular disease;
The alternative renin-angiotensin system: exploration of its therapeutic potentialSevá Pessôa B., PhDDanser A.H.J., prof. dr.Roks A.J.M., dr.Erasmus Universiteit Rotterdam (EUR)2015Pharmacology; Cardiovascular disease; Renin-angiotensin system;
The (pro)renin receptor: moving away from prorenin?Lu X., PhDDanser A.H.J., prof. dr.Meima M.E., dr.Erasmus Universiteit Rotterdam (EUR)2014Cardiovascular disease; Pharmacology; Prorenin;
Preeclampsia, the renin-angiotensin-aldosterone system and beyondVerdonk K., PhDDanser A.H.J., prof. dr.Erasmus Universiteit Rotterdam (EUR)2015Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system;
Integrated pharmaceutical care: cooperation between pharmacist, general practioner, and patient and the development of a pharmaceutical care planGeurts M.M.E., PhDGier J.J. de, prof. dr.Brouwers J.R.B.J., prof. dr.Graeff P.A. de, prof. dr.Rijksuniversiteit Groningen (RUG)2015
Medication safety in Vietnamese hospital: a focus on medication errors and safety cultureNguyen T.H., PhDTaxis K., prof. dr.Haaijer-Ruskamp F.M., prof. dr.Brouwers J.R.B.J., prof. dr.Rijksuniversiteit Groningen (RUG)2014
Driving-impairing medicines and traffic safety: patients' perspectivesMonteiro S.P., PhDGier J.J. de, prof. dr.Dijk C.E.M.J. van, dr. ir.Rijksuniversiteit Groningen (RUG)2014
Minimally invasive methodology for pharmacological research involving childrenKlein R.H., PhDCohen A.F., prof. dr.Burggraaf J., prof. dr.Sukhai R.N., dr.Universiteit Leiden (UL)2013Paediatrics; Clinical pharmacology; ADHD; Pharmacokinetics; Growth hormone deficiency; Pharmacodynamics; Point of care technology;
Neuropharmacology of novel dopamine modulators Beek E.T te, PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Dopamine Antagonist Drug development Pharmacokinetics Pharmacodynamics Schizophrenia Drug addiction Tachykinins
Non-invasive monitoring of pharmacokinetics and pharmacodynamics for pharmacological drug profiling in children and adolescentsSchrier L., PhDCohen A.F., prof. dr.Gerven J.M.A. van, prof. dr.Sukhai R.N., dr.Universiteit Leiden (UL)2015Non-invasive monitoring; Pharmacokinetics; Pharmacodynamics; Pharmacological drug profiling; Children; Adolescents;
Drug-induced psychomimetic symptoms as a model for psychosisKleinloog-Fernández González H.D., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Clinical Pharmacology Psychotic Disorders Clinical Trial Drug evaluation Biological Models
Exploring the role of glucagon in glucose homeostasisDongen M.G.J. van, PhDCohen A.F., prof. dr.Romijn J.A., prof drBurggraaf J., prof. dr.Universiteit Leiden (UL)2015Glucagon; Diabetes mellitus; Glucose homeostasis; Glucagon challenge; Glucagon receptor antagonist; Insulin
Novel approaches in clinical development of cannabinoid drugs Klumpers L.E., PhDGerven J.M.A. van, prof. dr.Cohen A.F., prof. dr.Universiteit Leiden (UL)2014Cannabinoids; THC; CB1 antagonists; Pharmacokinetics; Clinical pharmacology; Pharmacodynamics; Feeling high; PK-PD modelling; Resting state FMRI; Rimonabant;
Cognition in Huntington's disease : the influence of motor behaviour and time Hart E.P. 't, PhDRoos R.A.C., prof. dr.Universiteit Leiden (UL)2013Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour
The road to tailor made azole antifungal therapyBrüggemann R.J.M., PhDBurger D.M., prof. dr.Verweij P.E., prof. dr.Blijlevens N.M.A., dr.Radboud Universiteit (RU)2011Antifungal; clinical pharmacology
Clinical pharmacology of nevirapine in HIV-infected patients in TanzaniaMuro E.P., PhDBurger D.M., prof. dr.Dolmans W.M.V., prof. dr.Radboud Universiteit (RU)2014Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring
Assessment of ischaemia and reperfusion injuryWouters C.W., PhDRongen G.A., prof. dr.Oyen W.J.G., prof. dr.Radboud Universiteit (RU)2013Ischemia/reperfusion injury; adenosine; atorvastatin; forearm;
The role of efflux and influx transporters in the disposition of digitalis-like compoundsGozalpour E., PhDRussel F.G.M., prof. dr.Radboud Universiteit (RU)2015
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and diseaseWeigand K.M., PhDRussel F.G.M., prof. dr.Radboud Universiteit (RU)2015
New insights into the role of breast cancer resistance protein in endocrine and metabolic processesDankers A.C.A., PhDRussel F.G.M., prof. dr.Sweep C.G.J., prof. dr.Masereeuw R., prof. dr.Radboud Universiteit (RU)2014Cancer; Breast cancer;
Vascular adaptation to pregnancy and relaxinDrongelen J. van, PhDSmits P., prof. dr.Lotgering F.K., prof. dr.Radboud Universiteit (RU)2014
Medication safety through information technology; a focus on medication prescribing and administering.Helmons P.J., PhDKosterink J.G.W., prof. dr.Daniels C.E., prof. dr.Rijksuniversiteit Groningen (RUG)2014medication safety information technology prescribing and administering drugs
Loss of proteostasis as a substrate for Atrial Fibrilation.Meijering R.A.M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2014Atrial fibrillation; Proteostasis;
Patient perspectives in the benefit-risk evaluation of drugsVries S.T. de, PhDDenig P., prof. dr.Haaijer-Ruskamp F.M., prof. dr.Zeeuw D. de, prof. dr.Rijksuniversiteit Groningen (RUG)2015
The role of endogenous H2S production during hybernation and forced hypothermia: towards safe cooling and rewarming in clinical practiceDugbartey G.J., PhDHenning R.H., prof. dr.Bouma H.R., PhDRijksuniversiteit Groningen (RUG)2015
The influence of the sample matrix on LC-MS/MS method development and analytical performanceKoster R.A., PhDUges D.R.A., prof. dr.Kosterink J.G.W., prof. dr.Alffenaar J.W.C., prof. dr.Rijksuniversiteit Groningen (RUG)2015
Implications of the cardiomyocyte stress response on protein homeostasis in atrial fibrillationWiersma M., PhDHenning R.H., prof. dr.Brundel B.J.J.M., dr.Rijksuniversiteit Groningen (RUG)2016Atrial fibrillation;
Novel biomarker panels in diabetic kidney disease: predicting disease progression and response to therapy, and monitoring drug effectPena M.J., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2015Biomarkers; Diabetes mellitus; Kidney;
Immunological aspects of hibernation as leads in the prevention of acute organ injury.Bouma H.R., PhDHenning R.H., prof. dr.Kroese F.G.M., prof. dr.Strijkstra A.M., dr.Rijksuniversiteit Groningen (RUG)2013hibernation acute organ injury immunological
Statin treatment in type 2 diabetes patiëntsVries F.M. de, PhDHak E., prof. dr.Denig P., prof. dr.Postma M.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016Statins; Diabetes mellitus;
Drug-related problems: risk factors and the role of clinical pharmacistsZaal R.J., PhDVulto A.G., prof. dr.Haaijer-Ruskamp F.M., prof. dr.Bemt P.M.L.A. van den, dr.Erasmus Universiteit Rotterdam (EUR)2016Drug-related problems; Risk factors;
Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicineSchievink B.H., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016PRE score; Risk markers; Chronic kidney disease; Personalized medicine;
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimatesKröpelin T.F., PhDZeeuw D. de, prof. dr.Lambers Heerspink H.J., prof. dr.Rijksuniversiteit Groningen (RUG)2016Kidney; Diabetic kidney disease; Drug efficacy;
Go to page:
  • of 6